Skip to content

Mechanism Study on In-Stent Restenosis in Patients with Chronic Kidney Disease and Coronary Heart Disease: A Single-Center, Prospective Clinical Cohort Study

Mechanism Study on In-Stent Restenosis in Patients with Chronic Kidney Disease and Coronary Heart Disease: A Single-Center, Prospective Clinical Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118829
Enrollment
Unknown
Registered
2026-02-11
Start date
2026-02-11
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

non-CKD group:NA

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged >= 18 years and 90 ml/min/1.73m² (non-CKD); 4.The patient himself/herself or the designated agent consents to participate in this study; 5.Commits to complying with the research procedures and cooperating with the implementation of the entire research process;

Exclusion criteria

Exclusion criteria: 1.Allergy to iodine contrast agents; 2.Complicated with rheumatic immune diseases; 3.Complicated with malignant tumors; 4.Chronic infection during coronary artery stent implantation; 5.Familial hypercholesterolemia; 6.Patients with an expected lifespan of = 1 year; 7.Being pregnant or lactating; 8.Patients deemed by researchers to have poor compliance and unable to complete follow-up;

Design outcomes

Primary

MeasureTime frame
In-Stent Restenosis;

Secondary

MeasureTime frame
Incidence of MACE;

Countries

China

Contacts

Public ContactZhu Jinzhou

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

holmsfred@163.com+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026